| FT3 |
This study investigated the relationship between first-trimester thyroid hormone… |
Serum |
GDM(n=1177),Normal Glucose Tolerance(n=4718),assigned to quintile groups according serum FT3 levels
|
Chemiluminescent Immunoassay |
before 12th gestational weeks |
|
Effects of thyroid hormones modify the association between pre-pregnancy obesity and GDM: evidence from a mediation analysis |
2024 |
Frontiers in Endocrinology |
39345886 |
Risk factor |
| FT3 |
This study explored the association between free T3 (fT3), the fT3/fT4 ratio, an… |
Serum |
GDM(n=107),Normal Glucose Tolerance(n=214)
|
Electrochemiluminescence Immunoassay, ECLIA |
10th to 14th, 15th to 26th, 24th to 31th, and 33th to 39th gestational weeks |
|
A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes |
2018 |
Journal of Clinical Endocrinology & Metabolism |
29889229 |
Risk factor |
| FT4 |
This study investigated the relationship between thyroid hormone levels in early… |
Serum |
GDM(n=3697),Normal Glucose Tolerance(n=23816)
|
Chemiluminescent Microparticle Immunoassays |
9th to 13th gestational weeks |
|
Low Thyroid Hormone in Early Pregnancy Is Associated With an Increased Risk of Gestational Diabetes Mellitus |
2016 |
Journal of Clinical Endocrinology & Metabolism |
27583471 |
Risk factor |
| C-pep |
|
Serum |
|
Competitive Chemiluminescent Immunoassay |
10th to 14th gestational weeks & 15th to 20th gestational weeks |
|
Maternal fasting serum C-peptide concentrations in the first and second trimesters and subsequent risk of gestational diabetes mellitus: A nested case-control study among Chinese women |
2024 |
Diabetes Research And Clinical Practice |
38266822 |
Risk factor |
| ALT |
This study aimed to develop a predictive model for gestational diabetes mellitus… |
Serum |
(training, internal validation=7:3)GDM=137,NGDM=128;(external validation)133 pregnant women
|
Enzymatic Methods |
before 12th gestational weeks |
Logistic Regression |
Construction and validation of a line chart for gestational diabetes mellitus based on clinical indicators |
2024 |
Lipids in Health And Disease |
39462412 |
Risk factor |
| ALT |
This study investigated the relationship between liver function biomarkers in ea… |
Serum |
GDM(n=1688),Normal Glucose Tolerance(n=7480)(ALT,Q1:1-10U/L,Q2:11-13U/L,Q3:14-19U/L,Q4:20-87U/L)
|
Enzymatic Methods |
8th to 14th gestational weeks |
|
The associations of maternal liver biomarkers in early pregnancy with the risk of gestational diabetes mellitus: a prospective cohort study and Mendelian randomization analysis |
2024 |
Frontiers in Endocrinology |
38836232 |
Risk factor |
| Res |
This study investigated the roles of adipokines (leptin, resistin, and visfatin)… |
Serum |
GDM(n=70),Normal Glucose Tolerance(n=70)
|
ELISA |
11th to 13th gestational weeks |
|
Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus |
2019 |
Lipids in Health And Disease |
31836012 |
Risk factor |
| ANT |
Lung cancer remains the leading cause of cancer-related mortality worldwide, wit… |
|
|
|
|
|
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth |
2010 |
Nature Medicine |
20081861 |
Mechanism |
| Ins |
This study investigated whether elevated serum insulin levels in early pregnancy… |
Serum |
GDM(n=43),Normal Glucose Tolerance(n=28)
|
CLIA |
before 16th gestational weeks |
|
Prediction of gestational diabetes mellitus in a high-risk group by insulin measurement in early pregnancy |
2005 |
Diabetic Medicine |
16176208 |
Risk factor |
| FT4 |
This study investigated the relationship between thyroid function and the risk o… |
Serum |
GDM(n=444),Normal Glucose Tolerance(n=1767),assigned to quintile groups according serum FT4 levels
|
CLIA |
first antenatal visit |
|
Association between thyroid function and risk of gestational diabetes mellitus in assisted pregnancies: A retrospective cohort study |
2021 |
Diabetes Research And Clinical Practice |
33310125 |
Risk factor |